SCHEMBL24196885

SCHEMBL24196885

CCCN[S+]([O-])Cc1cccc(Br)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C19 P33261 2/20 0.47
TAAR1 Q96RJ0 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.38
IDO1 P14902 2/20 0.38
AGXT P21549 2/20 0.38
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
MAOB P27338 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24196899 0.81 TAAR1 (0.46) TAAR1IDO1AGXTCARM1PRMT6
SCHEMBL24196881 0.80 CYP1A2 (0.45) CYP1A2CYP2D6CYP2C19TAAR1L3MBTL1
SCHEMBL21928925 0.74 TAAR1 (0.47) CYP1A2CYP2D6CYP2C19TAAR1IDO1
SCHEMBL26622163 0.74 TAAR1 (0.47) CYP1A2CYP2D6CYP2C19TAAR1IDO1
SCHEMBL3565658 0.74 TAAR1 (0.50) CYP1A2CYP2D6CYP2C19TAAR1IDO1
SCHEMBL30837419 0.74 TAAR1 (0.50) CYP1A2CYP2D6CYP2C19TAAR1IDO1
SCHEMBL24196032 0.71 CHRM2 (0.39) L3MBTL1IDO1NPC1RAB9AALOX15
SCHEMBL6183546 0.71 CYP1A2 (0.76) CYP1A2CYP2D6CYP2C19TAAR1L3MBTL1
SCHEMBL552961 0.70 TAAR1 (0.66) CYP1A2CYP2D6CYP2C19TAAR1L3MBTL1
SCHEMBL13331747 0.69 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C19TAAR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022008475-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIVERSITE CLAUDE BERNARD LYON 1 (FR) 2022-01-13 WO disclosed